decisionhealth Newsletters, Part B News - 2011 Issue 2 (February)
Ask a Part B News Expert: Determining drug units
Subscribe or sign in to view the full article.
Article Overview
This article answers a practical Part B billing question about how drug units are determined from dosage information and how to review HCPCS entries when reporting injectable or inhaled medications. It is aimed at billers, coders, and other revenue cycle professionals who work with Medicare drug reporting and need a general understanding of how dose-based code selection is presented in the HCPCS manual.
Why This Topic Matters
Drug unit reporting affects claim accuracy and consistency when billing medications under Part B. The article helps readers understand the kind of HCPCS guidance available for dosage-based drug reporting and why reviewing the code family matters.
What You Will Learn
- How drug billing questions are framed in the context of HCPCS and the CMS drug fee schedule.
- Why medication entries in HCPCS may be organized by brand name or dosage.
- How the article approaches examples involving inhaled and injected drugs at a high level.
- The kinds of billing resources and code families used to review medication reporting.
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle professionals
- Part B providers
- DME billing staff
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com